Diamyd Medical Operating Income Over Time
| DMN Stock | EUR 1.39 0.07 4.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Diamyd Medical Performance and Diamyd Medical Correlation. Diamyd |
Cross Equities Operating Income Analysis
Compare Diamyd Medical AB and related stocks such as LEGACY IRON ORE, JD SPORTS FASH, and Hollywood Bowl Group Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A43 | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1 M) | (872.5 K) | (973 K) | (1 M) | (1 M) | (1.7 M) | (12.2 M) | (26.6 M) | (23.9 M) | (22.7 M) |
| 2H4 | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 24.9 M | 28.4 M | 9.9 M | 9.6 M | 57.6 M | 56.5 M | 60.6 M | 59.4 M | 68.3 M | 40.2 M |
| 9X8 | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 12.3 M | 15.3 M | 15.2 M | 13.7 M | 12.4 M |
| DDL | 19 B | 19 B | 19 B | 19 B | 20.4 B | 24.4 B | 25.5 B | 36.2 B | 33.8 B | 24.8 B | 10.1 B | 37 B | 47 B | 42.3 B | 39.4 B | 45.3 B | 33 B |
| 9RT | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (16.8 M) | (14.2 M) | 3.4 M | 3.9 M | 4.1 M |
Diamyd Medical AB and related stocks such as LEGACY IRON ORE, JD SPORTS FASH, and Hollywood Bowl Group Operating Income description
Operating Income is the amount of profit realized from Diamyd Medical AB operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Diamyd Medical AB is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Diamyd Medical AB | DMN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Kungsgatan 29, Stockholm, |
| Exchange | Frankfurt Exchange |
EUR 1.39
Other Information on Investing in Diamyd Stock
Diamyd Medical financial ratios help investors to determine whether Diamyd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diamyd with respect to the benefits of owning Diamyd Medical security.